Pharmaceutical Composition Containing An Anti-Nucleating Agent

Patent No. EP3165220 (titled "Pharmaceutical Composition Containing An Anti-Nucleating Agent") was filed by Merck Sharp & Dohme on Dec 2, 2005. The application was issued on Nov 13, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3165220

MERCK SHARP & DOHME
Application Number
EP16198994A
Filing Date
Dec 2, 2005
Status
Patent Maintained As Amended
Oct 11, 2024
Publication Date
Nov 13, 2024